These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25872125)

  • 1. Editorial Comment: Does gut-derived inflammation enhance pain signaling following chemotherapy in a Toll-like receptor 4-dependent manner?
    Wardill HR; Van Sebille YZ; Bowen JM; Gibson RJ
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):155-6. PubMed ID: 25872125
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4.
    Lin Y; Yu LX; Yan HX; Yang W; Tang L; Zhang HL; Liu Q; Zou SS; He YQ; Wang C; Wu MC; Wang HY
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1090-102. PubMed ID: 22617167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 in CNS pathologies.
    Buchanan MM; Hutchinson M; Watkins LR; Yin H
    J Neurochem; 2010 Jul; 114(1):13-27. PubMed ID: 20402965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflaming chronic pain.
    Leslie M
    Sci Aging Knowledge Environ; 2005 Apr; 2005(15):nf28. PubMed ID: 15829736
    [No Abstract]   [Full Text] [Related]  

  • 5. Toll-like receptor signaling: defensive or offensive for the heart?
    Hori M; Nishida K
    Circ Res; 2008 Feb; 102(2):137-9. PubMed ID: 18239139
    [No Abstract]   [Full Text] [Related]  

  • 6. Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity.
    Wardill HR; Van Sebille YZ; Mander KA; Gibson RJ; Logan RM; Bowen JM; Sonis ST
    Cancer Treat Rev; 2015 Feb; 41(2):122-8. PubMed ID: 25512119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 signalling in the intestine in health and disease.
    Fukata M; Abreu MT
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1473-8. PubMed ID: 18031248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.
    Garay RP; Viens P; Bauer J; Normier G; Bardou M; Jeannin JF; Chiavaroli C
    Eur J Pharmacol; 2007 Jun; 563(1-3):1-17. PubMed ID: 17383632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
    Chen R; Alvero AB; Silasi DA; Mor G
    Am J Reprod Immunol; 2007 Feb; 57(2):93-107. PubMed ID: 17217363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4.
    Heimesaat MM; Fischer A; Siegmund B; Kupz A; Niebergall J; Fuchs D; Jahn HK; Freudenberg M; Loddenkemper C; Batra A; Lehr HA; Liesenfeld O; Blaut M; Göbel UB; Schumann RR; Bereswill S
    PLoS One; 2007 Jul; 2(7):e662. PubMed ID: 17653282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Crosstalk between the liver and the gut: role of the microbiota in liver carcinogenesis].
    Faivre J; Bréchot C; Moniaux N
    Med Sci (Paris); 2013 Nov; 29(11):954-6. PubMed ID: 24280495
    [No Abstract]   [Full Text] [Related]  

  • 12. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
    Apetoh L; Ghiringhelli F; Tesniere A; Obeid M; Ortiz C; Criollo A; Mignot G; Maiuri MC; Ullrich E; Saulnier P; Yang H; Amigorena S; Ryffel B; Barrat FJ; Saftig P; Levi F; Lidereau R; Nogues C; Mira JP; Chompret A; Joulin V; Clavel-Chapelon F; Bourhis J; André F; Delaloge S; Tursz T; Kroemer G; Zitvogel L
    Nat Med; 2007 Sep; 13(9):1050-9. PubMed ID: 17704786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system.
    Brun P; Giron MC; Qesari M; Porzionato A; Caputi V; Zoppellaro C; Banzato S; Grillo AR; Spagnol L; De Caro R; Pizzuti D; Barbieri V; Rosato A; Sturniolo GC; Martines D; Zaninotto G; Palù G; Castagliuolo I
    Gastroenterology; 2013 Dec; 145(6):1323-33. PubMed ID: 23994200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 signaling promotes tumor growth.
    Lee CH; Wu CL; Shiau AL
    J Immunother; 2010 Jan; 33(1):73-82. PubMed ID: 19952954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation.
    Gribar SC; Anand RJ; Sodhi CP; Hackam DJ
    J Leukoc Biol; 2008 Mar; 83(3):493-8. PubMed ID: 18160540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roles of toll-like receptors in inflammation following injury].
    Du Q; Wang ZG; Ge HJ
    Sheng Li Ke Xue Jin Zhan; 2010 Jun; 41(3):221-4. PubMed ID: 21416986
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy-induced pain puzzles scientists.
    Savage L
    J Natl Cancer Inst; 2007 Jul; 99(14):1070-1. PubMed ID: 17623791
    [No Abstract]   [Full Text] [Related]  

  • 18. Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway.
    Gárate I; Garcia-Bueno B; Madrigal JL; Caso JR; Alou L; Gomez-Lus ML; Micó JA; Leza JC
    Biol Psychiatry; 2013 Jan; 73(1):32-43. PubMed ID: 22906518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone regulates c-reactive protein-induced inflammatory responses via glucocorticoid receptor-mediated inhibition of p38 mitogen-activated protein kinase-toll-like receptor 4 signal pathway in vascular smooth muscle cells.
    Liu N; Liu JT; Ji YY; Lu PP
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):348-56. PubMed ID: 21383592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system.
    Ciampricotti M; Hau CS; Doornebal CW; Jonkers J; de Visser KE
    Nat Med; 2012 Mar; 18(3):344-6; author reply 346. PubMed ID: 22395693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.